[Tricalcium phosphate implant in periodontal defects--initial 3 months].
The present study was performed to evaluate the effect of tricalcium phosphate implant in human osseous defects. 4 intraosseous defects in 2 patients were treated with mucoperiosteal flap and tricalcium phosphate (TCP) implant and another 5 defects in the same patients were debrided only via mucoperiosteal flap. The healing response was evaluated clinically 10-12 weeks after treatment. More reduction in probing depth and more gains in probing attachment levels were observed in implanted sites than in control sites.
Chung
H J
HJ
Chung
E H
EH
D001862:Bone Resorption / Q000601:surgery; D002130:Calcium Phosphates; D003757:Dental Implantation / Q000295:instrumentation*; D015921:Dental Implants; D004846:Epithelial Attachment; D006801:Humans; D010510:Periodontal Diseases / Q000601:surgery*
D002130:Calcium Phosphates; D015921:Dental Implants; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous